Status:
UNKNOWN
Unbound Bilirubin Levels in Healthy Term and Late Preterm Infants
Lead Sponsor:
Rutgers University
Conditions:
Neonatal Jaundice
Eligibility:
All Genders
6-7 years
Brief Summary
Specific Aim 1: To determine total serum bilirubin (TSB) and unbound bilirubin (Bf) levels in term and late preterm infants during the first week of life. Specific Aim 2: Measure Bf levels in breast ...
Eligibility Criteria
Inclusion
- Term and late-preterm infants admitted to the regular care nursery of Robert Wood Johnson University Hospital will be eligible for the study
Exclusion
- Infants suffering from genetic, chromosomal or surgical conditions will be excluded.
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2019
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03237715
Start Date
July 1 2017
End Date
June 30 2019
Last Update
August 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States, 08901